Staff Reporters
Nov 15, 2011

Interbrand appoints new global director of brand valuation

LONDON - Brand consultancy Interbrand has appointed Michael Rocha as global director of brand valuation, based at the company's London office.

Rocha will be leading Interbrand's brand valuation team
Rocha will be leading Interbrand's brand valuation team

Rocha, previously group managing director at Brand Finance, is tasked with overseeing the development of the brand valuation practice across 40 offices worldwide.

Brand valuation is at the heart of Intebrand's business and Rocha's appointment comes at a vital time, commented Interbrand's global chief executive officer Jez Frampton. "In the context of our current global economy, understanding how and why a business creates value has never been more critical."

Rocha has specialised in brand and business valuation for over a decade, both to support brand strategy decision-making and also for technical purposes such as financial reporting and tax. As managing director of Brand Finance, he led valuation and strategy assignments globally across a wide range of sectors.

 

Source:
Campaign Asia

Related Articles

Just Published

3 hours ago

Hindustan Unilever announces leadership changes, ...

The changes come as HUL reported a 6% decline in standalone net profit for the fiscal fourth quarter.

3 hours ago

Netflix reports strong Q1 growth but is it painting ...

Although Netflix has added almost 10 million new paid subscribers in early 2024, some experts believe advertising is quickly becoming the streaming giant’s long-term profitability plan, presenting a compelling opportunity for brands.

3 hours ago

Transphobic media organisations are alienating the ...

As part of Lesbian Visibility Week, the movement’s director says brands whose adspend drives the culture wars should expect to be shunned by the whole LGBTQIA+ community.

3 hours ago

Ogilvy launches health influencer marketing offering

Health Influence will combine Ogilvy PR’s global influencer team with experts from Ogilvy Health.